11 enrolling by invitation. 11 Phase 2, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Enrolling by invitation 11 |
| Phase 1 | 6 | Enrolling by invitation 6 |
Follow Neoplasms, Nerve Tissue: new trials by email Literature Review of Neoplasms, Nerve Tissue trials Research Report on Neoplasms, Nerve Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patients With High-grade Pancreatic Neuroendocrine Tumors Lurbinectedin 4 MG Injection [Zepzelca] - Neuroendocrine Tumor of Pancreas, Pancreatic Neuroendocrine Tumors | Phase 2 | Enrolling by invitation | National Cancer Center, Korea | 46 | 2025-09-23 | 2025-10-01 |
| Ultralow Dose PET Imaging of 18F-FDOPA 18F-FDOPA - Heathy Volunteer, Parkinsonian Syndromes | Phase 2 | Enrolling by invitation | Akiva Mintz | 200 | 2025-05-12 | 2026-04-21 |
| A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment Fianlimab+cemiplimab - Melanoma | Phase 2 | Enrolling by invitation | Regeneron Pharmaceuticals | 48 | 2025-04-14 | 2026-07-13 |
| Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA BNCT, ［18F］FBPA - Thoracic Solid Malignant Tumor | Phase 1 / Phase 2 | Enrolling by invitation | Stella Pharma Corporation | 30 | 2025-04-10 | 2025-11-19 |
| Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma Novel oncolytic virus Ad-TD-nsIL12 - Glioma | Phase 1 / Phase 2 | Enrolling by invitation | Xiaorong Wu | 40 | 2025-02-12 | 2026-03-23 |
| Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma. BioTTT001 injection - Recurrent High-grade Glioma | Phase 1 / Phase 2 | Enrolling by invitation | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 30 | 2024-11-26 | 2026-03-23 |
| Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis Sonodynamictherapy, Radiotherapy plus temozolomide - Glioma (Any Grade) in the Brain | Phase 2 | Enrolling by invitation | Yingjuan Zheng | 216 | 2024-10-01 | 2025-05-31 |
| Sonodynamic-Chemoradiotherapy Integration in Glioblastoma Sonodynamic Therapy (SDT), Standard Treatment - Glioblastoma (GBM) | Phase 2 | Enrolling by invitation | Yingjuan Zheng | 230 | 2024-10-01 | 2025-08-19 |
| Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors PET/CT （[18F]AlF-NOTA-PCP2）, [18F]AlF-NOTA-PCP2 PET/CT Imaging for PD-L1 Expression in Malignant Tumors - Glioblastoma (GBM), Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Enrolling by invitation | Man Hu | 100 | 2024-03-30 | 2025-03-30 |
| Melphalan Chemoreduction for Ocular Melanoma Melphalan Injection, Plaque brachytherapy - Uveal Melanoma | Phase 1 / Phase 2 | Enrolling by invitation | Hospital das Clínicas de Ribeirão Preto | 10 | 2021-05-01 | 2025-09-15 |
| The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells cytokine induced killer cells - Cholangiocarcinoma, Neuroblastoma | Phase 1 / Phase 2 | Enrolling by invitation | Siriraj Hospital | 20 | 2009-04-17 | 2025-02-10 |
Glioma (4) · Carcinoma, Non-Small-Cell Lung (2) · Esophageal Neoplasms (2) · Glioblastoma (2) · Melanoma (2) · Adenoma, Islet Cell (1) · Adenoviridae Infections (1) · Breast Neoplasms (1) · Cholangiocarcinoma (1) · Mesothelioma, Malignant (1) · Neoplasms (1) · Neuroblastoma (1) · Neuroendocrine Tumors (1) · Neurofibrosarcoma (1) · Parkinsonian Disorders (1)
Neoplasms by Histologic Type (11) · Neoplasms (10) · Neoplasms, Germ Cell and Embryonal (10) · Neuroectodermal Tumors (10) · Neoplasms, Glandular and Epithelial (9) · Neoplasms, Neuroepithelial (7) · Neoplasms by Site (5) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Adenoma (2) · Astrocytoma (2) · Bronchial Neoplasms (2)
Radiotherapy (2) · Blood Specimen Collection (1) · Brachytherapy (1) · Injections (1) · Magnetic Resonance Spectroscopy (1) · Melphalan (1) · PM 01183 (1) · Ruthenium-106 (1) · Temozolomide (1) · cemiplimab (1) · fluorodopa F 18 (1)
Yingjuan Zheng (2) · Akiva Mintz (1) · Beijing Bio-Targeting Therapeutics Technology Co., Ltd (1) · Hospital das Clínicas de Ribeirão Preto (1) · Man Hu (1) · National Cancer Center, Korea (1) · Regeneron Pharmaceuticals (1) · Siriraj Hospital (1) · Stella Pharma Corporation (1) · Xiaorong Wu (1)
China (5) · United States (2) · Brazil (1) · Ireland (1) · Japan (1) · South Korea (1) · Thailand (1)
Adisak Wongkajornsilp, M.D., Ph.D. (1) · Man Hu, Dr. (1) · Rodrigo Jorge, MD, PhD (1)